The Epidemiology, Diagnosis, and Cost of Dyspepsia and Helicobater pylori Gastritis: A Case-Control Analysis in the Southwestern United States

Helicobacter

Volumn 18, Issue 1, 2013, Pages 54-65

  Mapel, Douglas ^a   Roberts, Melissa ^a   Overhiser, Andrew ^b   Mason, Andrew ^c  

^a LOVELACE CLINIC FOUNDATION   (United States)

^b Northern Arizona Orthopaedics   (United States)

^c Southwest Gastroenterol Associates   (United States)

Author keywords

Cost; Dyspepsia; Epidemiology; Evaluation

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DYSPEPSIA; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COST OF ILLNESS; DYSPEPSIA; ETHNIC GROUPS; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SOUTHWESTERN UNITED STATES; YOUNG ADULT;

HELICOBACTER PYLORI;

EID: 84872387605     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2012.00988.x     Document Type: Article

References (36)

1. Bodger K, Daly MJ, Heatley RV, Williams DRR. Clinical economics review: gastroenterology. Aliment Pharmacol Ther 1996;10:55-60.
2. Bodger K, Eastwood PG, Manning SI, Daly MJ, Heatley RV. Dyspepsia workload in urban general practice and implications of the British Society of Gastroenterology Dyspepsia guidelines (1996). Aliment Pharmacol Ther 2000;14:413-20.
3. van Bommel MJ, Numans ME, de Wit NJ, Stalman WA. Consultations and referrals for dyspepsia in general practice-a one year database survey. Postgrad Med J 2001;77:514-8.
4. Maconi G, Tosetti C, Stanghellini V, Bianchi Porro G, Corinaldesi R. Dyspeptic symptoms in primary care. An observational study in general practice. Eur J Gastroenterol Hepatol 2002;14:985-90.
5. Wallander MA, Johansson S, Ruigomez A, Garcia Rodriguez LA, Jones R. Dyspepsia in general practice: incidence, risk factors, comorbidity and mortality. Fam Pract 2007;24:403-11.
6. Lee SY, Lee KJ, Kim SJ, Cho SW. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Digestion 2009;79:196-201.
7. Ford AC, Forman D, Bailey AG, Cook MB, Axon AT, Moayyedi P. Who consults with dyspepsia? Results from a longitudinal 10-yr follow-up study Am J Gastroenterol 2007;102:957-65.
8. McKinlay AW, Upadhyay R, Gemmell CG, Russell RI. Helicobacter pylori: bridging the credibility gap. Gut 1990;31:940-5.
9. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006;12:354-62.
10. Talley NJ. American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology 2005;129:1753-5.
11. Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology 2005;129:1756-80.
12. Moayyedi P, Deeks J, Talley NJ, Delaney B, Forman D. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. Am J Gastroenterol 2003;98:2621-6.
13. Mazzoleni LE, Sander GB, Francesconi CF, et al. Helicobacter pylori eradication in functional dyspepsia: HEROES trial. Arch Intern Med 2011;171:1929-36.
14. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.
15. Talley NJ, Fock KM, Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol 2008;103:510-4.
16. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
17. Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Do distinct dyspepsia subgroups exist in the community? A population-based study Am J Gastroenterol 2007;102:1983-9.
18. Ikenberry SO, Harrison ME, Lichtenstein D, Dominitz JA, Anderson MA, Jagannath SB, Banerjee S, Cash BD, Fanelli RD, Gan SI, Shen B, Van Guilder T, Lee KK, Baron TH. The role of endoscopy in dyspepsia. Gastrointest Endosc 2007;66:1071-5.
19. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000;53:1258-67.
20. Elixhauser A, Steiner C, Harris DR, Coffey RN. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27.
21. Vakil N, Moayyedi P, Fennerty MB, Talley NJ. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis. Gastroenterology 2006;131:390-401; quiz 659-60.
22. El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 2004;19:643-54.
23. Gerson LB, Kahrilas PJ, Fass R. Insights into gastroesophageal reflux disease-associated dyspeptic symptoms. Clin Gastroenterol Hepatol 2011;9:824-33.
24. Howden CW, Blume SW, de Lissovoy G. Practice patterns for managing Helicobacter pylori infection and upper gastrointestinal symptoms. Am J Manag Care 2007;13:37-44.
25. Wang YR, Richter JE, Dempsey DT. Trends and outcomes of hospitalizations for peptic ulcer disease in the United States, 1993 to 2006. Ann Surg 2010;251:51-8.
26. Kruszon-Moran D, McQuillan GM. Seroprevalence of six infectious diseases among adults in the United States by race/ethnicity: data from the third national health and nutrition examination survey, 1988-94. Adv Data 2005;352:1-9.
27. Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007;102:1808-25.
28. Fennerty MB. Helicobacter pylori: why it still matters in 2005. Cleve Clin J Med 2005;72(Suppl 2):S1-7; discussion S14-21.
29. Unit NGDaR. Management of dyspepsia in adults in primary care. Volume 2012. London: National Institute for Clinical Excellence, 2005. [WWW document.] URL: http://www.nice.org.uk/nicemedia/pdf/CG017NICEguideline.pdf (accessed: 22 March 2012).
30. Spiegel BM, Farid M, van Oijen MG, Laine L, Howden CW, Esrailian E. Adherence to best practice guidelines in dyspepsia: a survey comparing dyspepsia experts, community gastroenterologists and primary-care providers. Aliment Pharmacol Ther 2009;29:871-81.
31. Delaney BC, Qume M, Moayyedi P, Logan RF, Ford AC, Elliott C, McNulty C, Wilson S, Hobbs FD. Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial). BMJ 2008;336:651-4.
32. Barkun A, Crott R, Fallone C, et al. A one-year economic evaluation of six alternative strategies in the management of uninvestigated upper gastrointestinal symptoms in Canadian primary care. Can J Gastroenterol 2010;24:489-98.
33. Rabeneck L, Menke T. Increased numbers of women, older individuals, and Blacks receive health care for dyspepsia in the United States. J Clin Gastroenterol 2001;32:307-9.
34. Moayyedi P. The health economics of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 2007;21:347-61.
35. Delaney BC, Wilson S, Roalfe A, Roberts L, Redman V, Wearn A, Briggs A, Hobbs FD. Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care. Lancet 2000;356:1965-9.
36. Thirumurthi S, Desilva R, Castillo DL, Richardson P, Abraham NS. Identification of Helicobacter pylori infected patients, using administrative data. Aliment Pharmacol Ther 2008;28:1309-16.